Integrating Psychedelics with Evidence-Based Therapy

This reading and study group will maintain the same membership for the 12-week period. The group will have a syllabus with readings that participants will be expected to read prior to each discussion group meeting. The format for each session will include a short review of each paper by students in the course, followed by a discussion of the content and group members’ perspectives of the topic. This is an active group and weekly participation is required. The group is ideal for clinicians, graduate students, researchers, or the public, so long as they have training or interest in the scientific understanding of evidenced-based clinical interventions and their integration in psychedelic therapy. Readings will primarily include papers in the academic literature. Topics will include coverage of several different evidenced-based therapies (e.g., ACT, MI, CBT, DBT), several types of psychedelics (e.g., psilocybin, ketamine, MDMA), and a variety of clinical populations (e.g., depression, racial trauma, addiction, PTSD, life threatening illness). We will also critique the current state of psychedelic therapy research by reading and discussing articles about the role of indigenous knowledges, colonialism, inclusion of people of color, and limitation of white-dominant medical framework in psychedelic-assisted therapies.